Relation between pro-inflammatory cytokines and acetylcholine levels in relapsing-remitting multiple sclerosis patients

International Journal of Molecular Sciences

Volumn 13, Issue 10, 2012, Pages 12656-12664

  Reale, Marcella ^a   de Angelis, Federica ^b   di Nicola, Marta ^a   Capello, Elisabetta ^c   di Ioia, Maria ^a   de Luca, Giovanna ^a   Lugaresi, Alessandra ^a   Tata, Ada Maria ^b  

^a UNIVERSITY OF CHIETI   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Acetylcholine; Multiple sclerosis; Pro inflammatory cytokines

Indexed keywords

ACETYLCHOLINE; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA; INTERLEUKIN 1;

ADULT; AGE; AGED; ARTICLE; BLOOD ANALYSIS; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE EXACERBATION; FEMALE; HUMAN; INFLAMMATION; MALE; MOLECULAR PATHOLOGY; MULTIPLE SCLEROSIS; PATIENT ASSESSMENT; RELAPSE; BLOOD; CEREBROSPINAL FLUID; ENZYME LINKED IMMUNOSORBENT ASSAY; METABOLISM; MIDDLE AGED; PATHOLOGY; YOUNG ADULT;

ACETYLCHOLINE; ADULT; AGED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-1; INTERLEUKIN-17; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; YOUNG ADULT;

EID: 84867835356     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms131012656     Document Type: Article

References (27)

1. Filion, L.G.; Graziani-Bowering, G.; Matusevicius, D.; Freedman M.S. Monocyte-derived cytokines in multiple sclerosis. Clin. Exp. Immunol. 2003, 131, 324-334.
2. Lock, C.; Hermans, G.; Pedotti, R.; Brendolan, A.; Schadt, E.; Garren, H.; Langer-Gould A.; Strober, S.; Cannella, B.; Allard, J. et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 2002, 8, 500-508.
3. Zepp, J.; Wu, L.; Li, X. IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease. Trends Immunol. 2011, 32, 232-239.
4. Nizri, E.; Hamra-Amitay, Y.; Sicsic, C.; Lavon, I.; Brenner T. Anti-inflammatory properties of cholinergic up-regulation: A new role for acetylcholinesterase inhibitors. Neuropharmacology 2006, 50, 540-547.
5. De Angelis, F.; Bernardo, A.; Magnaghi, V.; Minghetti, L.; Tata, A.M. Muscarinic receptors subtypes as potential target to modulate oligodendrocyte progenitor survival, proliferation and differentiation. Dev. Neurobiol. 2012, 72, 713-728.
6. Kawashima, K.; Fujii, T. The lymphocytic cholinergic system and its contribution to the regulation of immune activity. Life Sci. 2003, 74, 675-696.
7. Rosas-Ballina, M.; Olafsson, P.S.; Ochani, M.; Valdes-Ferrer, S.L.; Levine, Y.A.; Reardon, C.; Tusche, M.W.; Pavlov, V.A.; Andersson, U.; Chavan, S. et al. Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science 2011, 334, 98-101.
8. Kawashima, K.; Fujii, T. Extraneuronal cholinergic system in lymphocytes. Pharmacol. Ther. 2000, 86, 29-48.
9. Shi, F.D.; Piao, W.H.; Kuo, Y.P.; Campagnolo, D.I.; Vollmer, T.; Lukas, R.J. Nicotinic attenuation of central nervous system inflammation and autoimmunity. J. Immunol. 2009, 182, 1730-1739.
10. Simpson, J.E.; Woodroofe, M.N. Inflammation in the central nervous system in multiple sclerosis: The role of chemokines and their receptors. Inflammopharmacology 2001, 9, 23-33.
11. Banks, W.A.; Robinson, S.M.; Verma, S.; Morley, J.E. Efflux of human and mouse amyloid beta proteins 1-40 and 1-42 from brain: Impairment in a mouse model of Alzheimer's disease. Neuroscience 2003, 121, 487-492.
12. De Simoni, M.G.; Sironi, M.; de Luigi, A.; Manfridi, A.; Mantovani, A.; Ghezzi, P. Intracerebroventricular injection of interleukin 1 induces high circulating levels of interleukin 6. J. Exp. Med. 1990, 171, 1773-1778.
13. DellaGioia, N.; Hannestad, J. A critical review of human endotoxin administration as an experimental paradigm of depression. Neurosci. Biobehav. Reviews 2010, 34, 130-143.
14. Lutterotti, A.; Berger, T.; Reindl, M. Biological markers for multiple sclerosis. Curr. Med. Chem. 2007, 14, 1956-1965.
15. Tzartos, J.S.; Friese, M.A.; Craner, M.J.; Palace, J.; Newcombe, J.; Esiri, M.M.; Fugger, L. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am. J. Pathol. 2008, 172, 146-155.
16. Wang, H.H.; Dai, Y.Q.; Qiu, W.; Lu, Z.Q.; Peng, F.H.; Wang, Y.G.; Bao, J.; Li, Y.; Hu, X.Q. Interleukin-17-secreting T cells in neuromyelitis optica and multiple sclerosis during relapse. J. Clin. Neurosci. 2011, 18, 1313-1317.
17. Lugaresi, A.; di Iorio, A.; Iarlori, C.; Reale, M.; de Luca, G.; Sparvieri, E.; Michetti, A.; Conti, P.; Gambi, D.; Abate, G. et al. IL-4 in vitro production is up-regulated in Alzheimer's disease patients treated with acetylcholinesterase inhibitors. Exp. Gerontol. 2004, 39, 653-657.
18. Reale, M.; Iarlori, C.; Gambi, F.; Feliciani, C.; Salone, A.; Toma, L.; de Luca, G.; Salvatore, M.; Conti, P.; Gambi, D. Treatment with an acetylcholinesterase inhibitor in Alzheimer patients modulates the expression and production of the pro-inflammatory and anti-inflammatory cytokines. J. Neuroimmunol. 2004, 148, 162-171.
19. Nizri, E.; Irony-Tur-Sinai, M.; Lory, O.; Orr-Urtreger, A.; Lavi, E.; Brenner, T. Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses. J. Immunol. 2010, 183, 6681-6688.
20. Nicolussi, E.M.; Huck, S.; Lassmann, H.; Bradl, M. The cholinergic anti-inflammatory system limits T cell infiltration into the neurodegenerative CNS, but cannot counteract complex CNS inflammation. Neurobiol. Diseases 2009, 35, 24-31.
21. De Kock, M.; Eisenacht, J.; Tong, C.; Schmitz, A.L.; Scholts, J.L. Analgesic doses intrathecal but not intravenous clonidine increase Acetylcholine in cerebrospinal fluid in humans. Anest. Analg. 1997, 84, 800-803.
22. Milara, J.; Serrano, A.; Peirò, T.; Amadeu, G.; Miralpeix, M.; Morcillo, E.J.; Cortijo, J. Aclidinium inhibits human lung fibroblast to myofibroblast transition. Thorax 2012, 97, 229-237.
23. Yamada, H.; Otsuka, M.; Fujimoto, M.; Kawashima, K.; Yoshida, M. Determination of acetylcholine concentration in cerebrospinal fluid of patients with neurologic diseases. Acta Neurol. Scand. 1996, 93, 76-78.
24. Dussor, G.O.; Helesic, G.; Hargreaves, K.M.; Flores, C.M. Cholinegic modulation of nociceptive responses in vivo and neuropeptide release in vitro at the level of the primary sensory neuron. Pain 2004, 107, 22-32.
25. Polman, C.H.; Reingold, S.C.; Edan, G.; Filippi, M.; Hartung, H.P.; Kappos, L.; Lublin, F.D.; Metz, L.M.; McFarland, H.F.; O'Connor, P.W.; et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann. Neurol. 2005, 58, 840-846.
26. Gallowitsch-Puerta, M.; Pavlov, V.A. Neuro-immune interactions via the cholinergic anti-inflammatory pathway. Life Sci. 2007, 80, 2325-2329.
27. Grando, S.A.; Kawashima, K.; Wessler, I. Introduction: The non-neuronal cholinergic system in humans. Life Sci. 2003, 72, 2009-2012.